Korteksin for children

General characteristics. Structure:

Active agent: кортексин (a complex of water-soluble polypeptide fractions) - 5 mg;
excipients: glycine (stabilizer) - 6 mg.

Pharmacological properties:

KORTEKSIN supports a complex of the low-molecular water-soluble polypeptide fractions getting through a blood-brain barrier directly to nervous cells. Drug renders nootropic, neurotyre-tread, antioxidant and tkanespetsifichesky action.

Nootropic – improves the highest functions of a brain, processes of training and memory, concentration of attention, stability at various stressful influences.

Neurotyre-tread – protects neurons from defeat by various internal neurotoxic causes (a glutamate, calcium ions, free radicals), reduces toxic effects of psychotropic substances.

Antioxidant – inhibits peroxide oxidation of lipids in neurons, increases survival of neurons in the conditions of an oxidative stress and a hypoxia.

Tkanespetsificheskoye – activates metabolism of neurons of the central and peripheral nervous system, reparative processes, promotes improvement of functions of a cerebral cortex and the general tone of a nervous system.

The mechanism of action of KORTEKSINA is caused by activation of peptides of neurons and neurotrophic factors of a brain; optimization of balance of metabolism of exciting and brake amino acids, dopamine, serotonin; Gamkergichesky influence; decrease in level of paroxysmal convulsive activity of a brain, ability to improve its bioelectric activity; prevention of formation of free radicals (products of peroxide oxidation of lipids).

 

Indications to use:

In complex therapy of disturbances of cerebral circulation, a craniocereberal injury and its effects, encephalopathies of various genesis, cognitive disturbances (dysmnesia and thinking), acute and chronic encephalitis and encephalomyelitis, epilepsy, asthenic states (nadsegmentarny vegetative frustration), reduced ability to training, delay of psychomotor and speech development in children, various forms of cerebral palsy.

Route of administration and doses:

The drug is administered intramusculary. Bottle contents before an injection waters for injections or 0,9% of solution of sodium of chloride (directing a needle to a bottle wall in order to avoid foaming) dissolve in 1–2 ml 0,5% of solution of Procainum (novocaine), and enter once daily: to children at body weight to 20 kg in a dose of 0,5 mg/kg, with body weight more than 20 kg – in a dose of 10 mg within 10 days.

If necessary conduct a repeated course in 3–6 months.

Features of use:

Drug is contraindicated at pregnancy (due to the lack of these clinical trials). In need of purpose of drug in the period of a lactation it is necessary to stop breastfeeding (due to the lack of these clinical trials).

Side effects:

Individual hypersensitivity to drug components is possible.

Interaction with other medicines:

Medicinal interaction of drug is not described.

Contraindications:

Individual intolerance of drug.

Overdose:

Now about cases of overdose of drug it was not reported.

Storage conditions:

In the dry, protected from light place, at a temperature from 2 to 20 to °s.khranit in the place, unavailable to children.

Issue conditions:

According to the recipe

Packaging:

Bottles of 5 ml (10) - packs cardboard.